Artículos del autor

solaci

Coronary disease

Bioresorbable Scaffolds Must Not Be Chosen Over Current DES

Although there are 4 approved bioresorbable scaffolds (BRS) in Europe, experts suggest that current drug-eluting stents (DES)...
solaci -
Institutional News

Congratulations to the winners of Colombia Sessions!

The past 05 and 06 of October, the 34th SOLACI Regional Sessions took place. During the event,...
solaci -
Structural heart disease

REPRISE III: Need for Pacemaker and Paravalvular Leak with Lotus

A recent presentation at London Valves took a closer look at the REPRISE III trial as regards two...
solaci -
Acute coronary syndromes

Impella Improves Safety in High Risk Unprotected Left Main PCI

Courtesy of Dr. Carlos Fava. The incidence of unprotected left main severe stenosis ranges between 4 and 8%,...
solaci -
Structural heart disease

Small Annulus: Should We Start Choosing the Valve?

Courtesy of Dr. Carlos Fava. A small annulus in patients with Severe Aortic Stenosis is a real challenge, since it...
solaci -
Most Read Scientific Articles

Tricuspid and Bicuspid Valves Present More Coincidences Than Expected

There is more and more positive evidence that new-generation transcatheter valves, originally designed to treat tricuspid aortic...
solaci -
Mitral valve

Transcatheter Reduction or Surgery for Paravalvular Leak Repair?

Paravalvular leak is complication derived from incomplete sealing between the implanted prosthesis and the native annulus, which...
solaci -
Institutional News

TCT 2017 Congress Coming Soon

The TCT 2017 Congress will take place from October 29th to November 2nd in Denver, Colorado. Check all the...
solaci -